Indeed, DCs from mProIFNa4-Fc-treated mice induced a significant increase of IFN-γ production from OT-I T cells even without additional OVA257-264 epitope in the ex vivo assay, which shows their enhanced ability to cross-prime tumor-specific CD8+ T cells (Fig. 4e). This evidence concerns the gene CD8A and neoplasm.